BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23321167)

  • 1. Mesothelin promotes invasion and metastasis in breast cancer cells.
    Wang Y; Wang L; Li D; Wang HB; Chen QF
    J Int Med Res; 2012; 40(6):2109-16. PubMed ID: 23321167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
    Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
    Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
    Uehara N; Matsuoka Y; Tsubura A
    Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
    Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS
    Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
    Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D
    J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
    Oh E; Kim JY; Cho Y; An H; Lee N; Jo H; Ban C; Seo JH
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1071-81. PubMed ID: 26975580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
    Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
    Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
    Winding B; NicAmhlaoibh R; Misander H; Høegh-Andersen P; Andersen TL; Holst-Hansen C; Heegaard AM; Foged NT; Brünner N; Delaissé JM
    Clin Cancer Res; 2002 Jun; 8(6):1932-9. PubMed ID: 12060638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
    Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
    Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.
    Mira E; Lacalle RA; Buesa JM; de Buitrago GG; Jiménez-Baranda S; Gómez-Moutón C; Martínez-A C; Mañes S
    J Cell Sci; 2004 Apr; 117(Pt 9):1847-57. PubMed ID: 15075244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
    Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
    Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-κB/MMP-9 pathway.
    Park SL; Kim WJ; Moon SK
    Int Immunopharmacol; 2014 Sep; 22(1):59-65. PubMed ID: 24953855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of mesothelin expression in invasive breast cancer.
    Wang L; Niu Z; Zhang L; Liu X; Wang X; Li F; Wang Y
    J Int Med Res; 2012; 40(3):909-16. PubMed ID: 22906263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.
    Fan SH; Wang YY; Lu J; Zheng YL; Wu DM; Zhang ZF; Shan Q; Hu B; Li MQ; Cheng W
    J Cell Biochem; 2015 Apr; 116(4):502-13. PubMed ID: 25213553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.